Keros Therapeutics, Inc.

KROS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001664710

SEC filings (opens in a new tab)

In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Keros Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of KROS: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	104	113	+9
Shares	17.4M	18.1M	+718.8K (+4.1%)
Value	$479.7M	$680.1M	+$200.4M (+41.8%)

New holders (24)

Institutions that held Keros Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to KROS in Q3 2022
Institution	Shares	Value	% of portfolio
Woodline Partners LP	342,493	$12.9M	0.19%
CIBC Asset Management Inc	146,368	$5.51M	0.02%
Soleus Capital Management, L.P.	146,000	$5.49M	0.75%
Point72 Asset Management, L.P.	91,840	$3.46M	0.02%
Voya Investment Management LLC	87,410	$3.29M	0.00%
Susquehanna International Group, LLP	36,022	$1.35M	0.00%
Russell Investments Group, Ltd.	24,859	$934.0K	0.00%
BNP Paribas Arbitrage, SA	22,427	$843.7K	0.00%
Caption Management, LLC	20,000	$753.0K	0.13%
Prudential Financial Inc	11,237	$423.0K	0.00%
Price T Rowe Associates Inc	9,730	$367.0K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	9,620	$362.0K	0.00%
J. Goldman & Co LP	8,416	$317.0K	0.02%
Virtus Investment Advisers, Inc.	8,113	$305.0K	0.14%
Invesco Ltd.	8,056	$303.0K	0.00%
Manufacturers Life Insurance Company, The	6,811	$256.2K	0.00%
STRS Ohio	5,300	$199.0K	0.00%
Allspring Global Investments Holdings, LLC	2,149	$80.0K	0.00%
Almanack Investment Partners, LLC.	884	$32.0K	0.01%
China Universal Asset Management Co., Ltd.	241	$9.00K	0.00%
Nisa Investment Advisors, LLC	15	$1.00K	0.00%
Wipfli Financial Advisors LLC,	21	$1.00K	0.00%
Signaturefd, LLC	10	$0	0.00%
Parallel Advisors, LLC	4	$0	0.00%

Sold out (15)

Institutions that held Keros Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of KROS in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Octagon Capital Advisors LP	152,249	$4.21M
Two Sigma Investments, LP	55,561	$1.53M
Marshall Wace, LLP	52,934	$1.46M
Altshuler Shaham Ltd	34,074	$941.0K
Jane Street Group, LLC	33,356	$921.0K
D. E. Shaw & Co., Inc.	21,056	$582.0K
HighVista Strategies LLC	16,623	$459.0K
Trexquant Investment LP	14,341	$396.0K
Bank of Montreal	11,613	$336.0K
Dynamic Technology Lab Private Ltd	10,020	$277.0K
Quantbot Technologies LP	6,364	$175.0K
Point72 Hong Kong Ltd	1,006	$28.0K
High Net Worth Advisory Group LLC	500	$14.0K
Group One Trading, L.P.	100	$3.00K
Federated Hermes, Inc.	74	$2.00K